Lightnews — Scholar-powered news

Reposted by Oliver Tavabie

ToRcH-UK @torchuk.bsky.social · 13d

📣 Our next project #EVADE is officially LIVE! 📣

Site registration is open to hospitals across the UK. Project dashboard: redcap.link/evade

But what is #EVADE and why should you be interested in collaborating with us?

#liversky #gastrosky @otavabie.bsky.social @chrismysko.bsky.social

(1/6)

1 1 3

Oliver Tavabie @otavabie.bsky.social · 22d

Read our new work developing a patient reported experience survey for outpatients with liver disease and the accompanying feasibility study! Significant challenges remain to improve liver patient participation in surveys #liversky

fg.bmj.com/content/earl...

3

Oliver Tavabie @otavabie.bsky.social · May 28

Read the paper here
fg.bmj.com/content/16/3/239

Role of anti-diabetic medications in the management of MASLD

Metabolic dysfunction-associated steatotic liver disease (MASLD) poses a significant global health challenge due to its rising prevalence and strong association with metabolic syndrome and type 2 diab...

fg.bmj.com

1 1

Oliver Tavabie @otavabie.bsky.social · May 28

It was a real pleasure to interview Scott Isaacs and @paulnbrennan.bsky.social regarding their recent paper on 'Anti-diabetic medications in MASLD' in Frontline Gastroenterology - listen below

fgbmj.podbean.com/e/role-of-anti-diabetic-medications-in-the-management-of-masld/

Role of anti-diabetic medications in the management of MASLD | FG Podcast

The use of anti-diabetic medications such as pioglitazone or GLP-1 receptor agonists in the management of metabolic dysfunction-associated steatotic liver disease (MASLD) is discussed in this podcast....

fgbmj.podbean.com

1 1 6

Reposted by Oliver Tavabie

Feather Moore @feathermoore.bsky.social · May 21

This overview summarizes clinical tools that assess nutritional status and physical frailty, with the benefits and future challenges of a multidisciplinary team approach to optimise muscle health and physical fitness in patients with decompensated cirrhosis.

fg.bmj.com/content/earl...

1 1

Reposted by Oliver Tavabie

The Baveno Cooperation: an EASL Consortium @bavenocoop.bsky.social · May 5

🇳🇱 Join us at #EASL2025 in Amsterdam 🇳🇱

📅 Thu 08 May
08:30–09:45 | Future of Hepatology: Endohepatology
10:00–10:30 | Baveno @ EASL Track Hub (Cirrhosis & Complications)

📅 Fri 09 May
12:00–13:30 | Baveno General Assembly (Room D201, members only)

#LiverTwitter

4 4

Oliver Tavabie @otavabie.bsky.social · May 5

Am looking forward to the ILC this week - not just to catch up with the community but to look for submissions to
Frontline Gastroenterology. Do get in contact with me if you want to talk about your work and ideas for manuscripts!
#Liversky @easlnews.bsky.social @bavenocoop.bsky.social

Reposted by Oliver Tavabie

Oliver Tavabie @otavabie.bsky.social · Apr 16

Fantastic to see the updated BSG/BASL decompensated cirrhosis admission bundle in print at FG
- practical guidance to improve care in the first 24 hours as well as implementation strategy - congrats Stuart McPherson for driving this! #livertwitter

fg.bmj.com/content/earl...

Decompensated cirrhosis: an update of the BSG/BASL admission care bundle

Acute decompensated cirrhosis (DC) and acute-on-chronic liver failure are common reasons for hospital admission that have a high in-hospital mortality rate (10%–20%). Patients require a detailed asses...

fg.bmj.com

6 10

Oliver Tavabie @otavabie.bsky.social · Apr 16

Fantastic to see the updated BSG/BASL decompensated cirrhosis admission bundle in print at FG
- practical guidance to improve care in the first 24 hours as well as implementation strategy - congrats Stuart McPherson for driving this! #livertwitter

fg.bmj.com/content/earl...

Decompensated cirrhosis: an update of the BSG/BASL admission care bundle

Acute decompensated cirrhosis (DC) and acute-on-chronic liver failure are common reasons for hospital admission that have a high in-hospital mortality rate (10%–20%). Patients require a detailed asses...

fg.bmj.com

6 10

Reposted by Oliver Tavabie

Oliver Tavabie @otavabie.bsky.social · Apr 8

Great to see our paper examining real-world applicability of telemonitoring interventions published in FG! Fantastic working with Dee Kumar, Kohi Gananandan, @jennieclough.bsky.social and Guy Robinson on this! #livertwitter #gitwitter

fg.bmj.com/content/early/2025/04/08/flgastro-2024-102997

1 2 7

Reposted by Oliver Tavabie

Pierre Gholam MD @livermd.bsky.social · Apr 10

Time for the liver community to say it loudly, nonjudgementally & consistently:

There is no safe level of alcohol consumption

@easlnews.bsky.social is leading the way to defend mandatory labels on alc. beverages in the EU.
It’s time for @aasldnews.bsky.social to do the same in the US
#liversky

1 3

Oliver Tavabie @otavabie.bsky.social · Apr 8

Furthermore, there seems to be limited coverage/inclusion of LMICs and non-English language options for interventions. Standardised reporting and a focus on undeserved populations will improve and maximise the potential impact of telemonitoring interventions

Oliver Tavabie @otavabie.bsky.social · Apr 8

Whilst telemonitoring represents an opportunity to increase access to healthcare across settings and prioritise resource delivery - there are significant limitations in the reporting of current studies which prevent understanding of cohorts engaging with interventions

1

Oliver Tavabie @otavabie.bsky.social · Apr 8

Great to see our paper examining real-world applicability of telemonitoring interventions published in FG! Fantastic working with Dee Kumar, Kohi Gananandan, @jennieclough.bsky.social and Guy Robinson on this! #livertwitter #gitwitter

fg.bmj.com/content/early/2025/04/08/flgastro-2024-102997

1 2 7

Reposted by Oliver Tavabie

Elliot Tapper @ebtapper.bsky.social · Apr 4

Let’s talk about sex

journals.lww.com/hepcomm/full... #liversky

3 9

Oliver Tavabie @otavabie.bsky.social · Mar 31

Thanks to all that completed the first round of the UK CLIF JLA research priority setting process for decompensated cirrhosis - if you live with or care/work with patients with cirrhosis - please take some time to go through these research questions #livertwitter

www.surveymonkey.com/r/SMMF6XJ

Survey: Priorities for Liver Cirrhosis Research

Take this survey powered by surveymonkey.com. Create your own surveys for free.

www.surveymonkey.com

1 3

Oliver Tavabie @otavabie.bsky.social · Mar 3

Read the original paper here

journals.lww.com/lt/abstract/...

Cognitive dysfunction, psychiatric distress, and functional ... : Liver Transplantation

erformance using a telephone-based battery. We compared depression, anxiety, and self-reported function by cognitive performance using descriptive statistics. Among 120 participants (median age 65, me...

journals.lww.com

Oliver Tavabie @otavabie.bsky.social · Mar 3

Great to see #JadeKing any my editorial in @LTxJournal
journals.lww.com/lt/citation/...
discussing the psychological and cognitive impact of liver disease and transplantation on patients as well as the potential role of prehabilitation in addressing this #liversky

The long and winding road to maximize the benefit of Liver... : Liver Transplantation

An abstract is unavailable. This article is available as a PDF only.

journals.lww.com

1 2

Oliver Tavabie @otavabie.bsky.social · Mar 3

Read the original paper here

journals.lww.com/lt/abstract/...

Cognitive dysfunction, psychiatric distress, and functional ... : Liver Transplantation

erformance using a telephone-based battery. We compared depression, anxiety, and self-reported function by cognitive performance using descriptive statistics. Among 120 participants (median age 65, me...

journals.lww.com

Oliver Tavabie @otavabie.bsky.social · Feb 21

New review in #FG from @paulnbrennan.bsky.social and #scottisaacs - a great summary of the role of antidiabetic medications in MASLD #liversky

fg.bmj.com/content/earl...

Role of anti-diabetic medications in the management of MASLD

Metabolic dysfunction-associated steatotic liver disease (MASLD) poses a significant global health challenge due to its rising prevalence and strong association with metabolic syndrome and type 2 diab...

fg.bmj.com

2 2

Oliver Tavabie @otavabie.bsky.social · Feb 17

Hear hear!

2

Reposted by Oliver Tavabie

Rob Brierley @robbrierley.bsky.social · Feb 17

"Alcohol labels should warn of cancer risk" - new WHO report

www.who.int/europe/news-...

#LiverSky #MedSky @who.int

Alcohol labels should warn of cancer risk, says new WHO/Europe report

Copenhagen, 14 February 2025Prominent health warning labels on alcoholic beverages are essential for raising awareness that consuming alcohol can lead to cancer. This simple and inexpensive measure ca...

www.who.int

1 4 13

Oliver Tavabie @otavabie.bsky.social · Feb 16

us02web.zoom.us/webinar/regi...

Join us for our next BLTG webinar on Organ Allocation on the 3rd of April - lots to talked about! #liversky

Video Conferencing, Web Conferencing, Webinars, Screen Sharing

Zoom is the leader in modern enterprise video communications, with an easy, reliable cloud platform for video and audio conferencing, chat, and webinars across mobile, desktop, and room systems. Zoom ...

us02web.zoom.us

2

Reposted by Oliver Tavabie

Elliot Tapper @ebtapper.bsky.social · Feb 13

Lieber is a liver leader

We want our patients to thrive after transplant

She advocates for tailored, enriched POST transplant care for people at risk of poor outcomes

And it is about time

#liversky

1 4

Reposted by Oliver Tavabie

Resham Ramkissoon, MD @rayrammd.bsky.social · Feb 13

The correct term is conjunctival icterus.

The expression "scleral icterus" was previously and incorrectly perpetuated. See this scathing remark in @jama.com by an ophthalmologist.

jamanetwork.com/journals/jam...

#Liversky #GiSky #Medsky @cwruim.bsky.social

'Conjunctival Icterus,' Not 'Scleral Icterus'

To the Editor.— The expression "scleral icterus" generally used by physicians is grossly incorrect. For decades, physical diagnosis primers have cued medical students to look for "scleral icterus...

jamanetwork.com

1 4 9